CNGR(300919)

Search documents
中伟股份2023年报及2024年一季报点评:出货稳定增长,看好镍资源布局增厚盈利
长江证券· 2024-05-13 23:32
%% research.95579.com %% 丨证券研究报告丨 联合研究丨公司点评丨中伟股份( ) 300919.SZ [中Ta伟b股le_份Ti2tl0e2] 3 年报及 2024 年一季报点评: 出货稳定增长,看好镍资源布局增厚盈利 报告要点 [中Ta伟bl股e_份Su发m布ma2r0y2]3年年报及2024年一季报,2023年公司实现营业收入342.73亿元,同比 增长12.95%,实现归属净利润19.47亿元,同比增长26.15%,实现扣非净利润15.87亿元, 同比增长43.13%;拆分至四季度,公司实现营业收入80.83亿元,同比增长0.31%,归属净 利润5.6亿元,同比增长22.19%,实现扣非净利润4.56亿元,同比增长40.21%。2024Q1实 ...
中伟股份:关于参加深圳证券交易所民营经济迈新阶集体业绩说明会的公告
2024-05-13 10:23
证券代码:300919 证券简称:中伟股份 公告编号:2024-041 中伟新材料股份有限公司 关于参加深圳证券交易所"民营经济迈新阶" 集体业绩说明会的公告 本公司及董事会全体成员保证公告内容真实、准确和完整,不存在任何虚假记载、误 导性陈述或者重大遗漏。 中伟新材料股份有限公司(以下简称"公司")将于 2024 年 5 月 16 日(星期四)15: 00-17:30 参加由深圳证券交易所(以下简称"深交所")组织召开的以"民营经济迈新阶" 为主题的集体业绩说明会活动,现将有关事项公告如下: 一、本次业绩说明会的安排 (一)召开时间:2024 年 5 月 16 日(星期四)15:00-17:30 (二)召开地点:深交所 811 国际会议厅 (四)公司出席人员:公司董事长兼总裁邓伟明先生、副总裁兼财务总监朱宗元先生、 保荐代表人金巍锋先生(具体参会人员以当天实际出席人员为准)。 二、投资者问题征集方式 为充分尊重投资者、提升交流的针对性,现就本次业绩说明会提前向投资者公开征集问 题,广泛听取投资者的意见和建议。投资者可提前登陆深交所"互动易"平台 (http://irm.cninfo.com.cn)"云访谈" ...
中伟股份:华泰联合证券有限责任公司关于中伟新材料股份有限公司首次公开发行股票并在创业板上市之保荐总结报告书
2024-05-12 08:48
首次公开发行股票并在创业板上市 之保荐总结报告书 | 保荐机构名称 | 华泰联合证券有限责任公司 | | --- | --- | | 保荐机构编号 | Z26774000 | 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导 性陈述或重大遗漏,保荐机构及保荐代表人对其真实性、准确性、完整性承担法 律责任。 保荐总结报告书 华泰联合证券有限责任公司 关于中伟新材料股份有限公司 2、本机构及本人自愿接受中国证券监督管理委员会(以下简称"中国证监 会")、深圳证券交易所对保荐总结报告书相关事项进行的任何质询和调查。 3、本机构及本人自愿接受中国证监会按照《证券发行上市保荐业务管理办 法》的有关规定采取的监管措施。 二、保荐机构基本情况 | 情况 | 内容 | | --- | --- | | 保荐机构名称 | 华泰联合证券有限责任公司 | | 注册地址 | 深圳市前海深港合作区南山街道桂湾五路 128 号前海深港基金小 | | | 镇 B7 栋 401 | | 主要办公地址 | 广东省深圳市福田区莲花街道益田路 5999 号基金大厦 27 层及 28 | | | 层 | ...
中伟股份:华泰联合证券有限责任公司关于中伟新材料股份有限公司2021年向特定对象发行股票并在创业板上市之保荐总结报告书
2024-05-12 08:48
保荐总结报告书 华泰联合证券有限责任公司 关于中伟新材料股份有限公司 2021 年向特定对象发行股票并在创业板上市 之保荐总结报告书 | 保荐机构名称 | 华泰联合证券有限责任公司 | | --- | --- | | 保荐机构编号 | Z26774000 | 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导 性陈述或重大遗漏,保荐机构及保荐代表人对其真实性、准确性、完整性承担法 律责任。 2、本机构及本人自愿接受中国证券监督管理委员会(以下简称"中国证监 会")、深圳证券交易所对保荐总结报告书相关事项进行的任何质询和调查。 3、本机构及本人自愿接受中国证监会按照《证券发行上市保荐业务管理办 法》的有关规定采取的监管措施。 二、保荐机构基本情况 | 情况 | 内容 | | --- | --- | | 保荐机构名称 | 华泰联合证券有限责任公司 | | 注册地址 | 深圳市前海深港合作区南山街道桂湾五路 128 号前海深港基金小 | | | 镇 B7 栋 401 | | 主要办公地址 | 广东省深圳市福田区莲花街道益田路 5999 号基金大厦 27 层及 28 | ...
中伟股份:关于举办2024年投资者集体接待日暨2023年度业绩说明会并征集问题的公告
2024-05-06 07:48
证券代码:300919 证券简称:中伟股份 公告编号:2024-040 中伟新材料股份有限公司(以下简称"公司")已于 2024 年 4 月 24 日在巨潮资讯网 (www.cninfo.com.cn)上披露了《2023 年年度报告》及《2023 年年度报告摘要》。为加强 公司与投资者的交流互动,便于投资者进一步了解公司 2023 年度经营情况及其他关切问题, 在贵州证监局指导下,贵州证券业协会联合深圳市全景网络有限公司举办 2024 年贵州辖区 上市公司投资者集体接待日暨 2023 年度业绩说明会并征集相关问题,具体安排如下: 一、业绩说明会的安排 (一)召开时间 2024 年 5 月 9 日 15:40-17:30 (二)召开方式 网络远程方式。 中伟新材料股份有限公司 关于举办2024年投资者集体接待日 暨2023年度业绩说明会并征集问题的公告 本公司及董事会全体成员保证公告内容真实、准确和完整,不存在任何虚假记载、误 导性陈述或者重大遗漏。 投资者可登录 http://rs.p5w.net 进入专区页面参与交流。 二、投资者问题提前征集 为广泛听取投资者的意见和建议、提升交流效率及针对性,本次业绩说明 ...
中伟股份:关于公司回购股份进展的公告
2024-05-06 07:48
本公司及董事会全体成员保证公告内容真实、准确和完整,不存在任何虚假记载、误 导性陈述或者重大遗漏。 中伟新材料股份有限公司(以下简称"公司")于 2023 年 8 月 24 日召开的第二届董事 会第八次会议、第二届监事会第六次会议,审议通过了《关于公司以集中竞价交易方式回购 公司股份方案的议案》,公司决定使用自有资金以集中竞价方式回购公司股份用于股权激励 或员工持股计划。回购资金总额不低于人民币 18,000 万元(含)且不超过人民币 29,000 万 元(含),回购股份价格不超过人民币 88 元/股,回购股份期限为董事会审议通过回购股份 方案之日起 12 个月内,具体回购股份数量以回购期满时实际回购的股份数量为准。具体内 容详见公司于 2023 年 8 月 25 日在创业板指定网站巨潮资讯网(www.cninfo.com.cn)上披露 的《关于公司以集中竞价交易方式回购公司股份的方案》等公告。 一、公司回购股份的进展情况 根据《深圳证券交易所股票上市规则》、《上市公司股份回购规则》及《深圳证券交易 所上市公司自律监管指引第 9 号-回购股份》等相关规定,上市公司应当在每个月的前三个 交易日内披露截至上月末的 ...
报告之七:23年及24Q1业绩点评,业绩符合预期,一体化持续深入
国泰君安· 2024-04-28 06:02
股 票 研 究 [Table_industryInfo] 资本货物/工业 [ Table_Main[中ITnaf 伟bol]e 股_Ti份tle]( 300919) [评Tab级le_:Inv est] 增持 上次评级: 增持 业绩符合预期,一体化持续深入 目标价格: 58.68 上次预测: 57.60 公 ——中伟股份报告之七:23年及 24Q1 业绩点评 当前价格: 50.91 司 庞钧文(分析师) 牟俊宇(分析师) 2024.04.28 更 021-38674703 0755-23976610 [交Ta易bl数e_M据a rket] 新 pangjunwen@gtjas.com moujunyu@gtjas.com 证书编号 S0880517120001 S0880521080003 52周内股价区间(元) 41.47-63.67 报 总市值(百万元) 34,101 告 本报告导读: 总股本/流通A股(百万股) 670/649 流通 B股/H股(百万股) 0/0 公司23年及24Q1业绩基本符合预期。在公司镍矿冶炼-中间品一体化布局持续深入 流通股比例 97% 及镍钴磷钠产品全线推进推动下,公司有望在2 ...
2023年年报及2024年一季报点评:盈利能力稳健,全球化、一体化布局领先
光大证券· 2024-04-26 11:02
Investment Rating - The report maintains a "Buy" rating for the company [3] Core Views - The company demonstrated robust profitability with a 2023 revenue of 34.273 billion, a year-on-year increase of 12.95%, and a net profit of 1.947 billion, up 26.11% year-on-year [2] - The company is a leader in ternary precursor production, holding a 27% market share in 2023, despite a revenue decline in this segment [2][3] - The company is benefiting from strong overseas demand, with significant revenue growth from key clients such as Tesla and LG Chem [2] Summary by Sections Financial Performance - In Q4 2023, the company reported a revenue of 8.083 billion, a slight increase of 0.31% year-on-year, but a decrease of 9.43% quarter-on-quarter [2] - Q1 2024 revenue reached 9.292 billion, marking a 17.58% year-on-year increase and a 14.97% quarter-on-quarter increase [2] - The gross margin for Q1 2024 was 13.52%, down 2.93 percentage points from the previous quarter but up 2.30 percentage points year-on-year [2] Market Position - The company has established nearly 400,000 tons/year of ternary precursor capacity and is expanding its resource integration globally [3] - The company achieved a ternary precursor revenue of 21.733 billion in 2023, with a gross margin of 17.96%, an increase of 5.36 percentage points from the previous year [2][3] Growth Prospects - The report forecasts a decrease in net profit estimates for 2024 and 2025 due to product price reductions, projecting net profits of 2.345 billion and 2.746 billion respectively [3] - The company is expected to benefit from increasing overseas demand, maintaining its leading position in the industry [3]
2024年一季报点评:Q1少数股东权益影响利润,一体化支撑后续盈利
东吴证券· 2024-04-26 08:02
证券研究报告·公司点评报告·电池 中伟股份(300919) 2024 年一季报点评:Q1 少数股东权益影响 2024 年 04月 26日 利润,一体化支撑后续盈利 证券分析师 曾朵红 买入(维持) 执业证书:S0600516080001 021-60199793 盈[T 利ab 预le_ 测EP 与S 估] 值 2022A 2023A 2024E 2025E 2026E zengdh@dwzq.com.cn 证券分析师 阮巧燕 营业总收入(百万元) 30,344 34,273 39,861 47,850 56,644 执业证书:S0600517120002 同比(%) 51.17 12.95 16.30 20.04 18.38 021-60199793 归母净利润(百万元) 1,543 1,947 2,365 2,846 3,473 ruanqy@dwzq.com.cn 同比(%) 64.33 26.15 21.50 20.32 22.04 证券分析师 岳斯瑶 EPS-最新摊薄(元/股) 2.30 2.91 3.53 4.25 5.18 执业证书:S0600522090009 P/E(现价&最新摊薄) 21. ...
中伟股份(300919) - 2024 Q1 - 季度财报
2024-04-25 12:03
Financial Performance - The company's operating revenue for Q1 2024 was ¥9,292,228,538.39, representing a 17.58% increase compared to ¥7,902,791,580.39 in the same period last year[3] - Net profit attributable to shareholders was ¥379,138,599.25, an increase of 11.19% from ¥340,969,264.18 year-on-year[3] - The company reported a basic earnings per share of ¥0.57, up 11.76% from ¥0.51 in the previous year[3] - The company's net profit after deducting non-recurring gains and losses was ¥339,942,641.80, which is a 34.64% increase from ¥252,481,726.80 in the same period last year[3] - Net profit for Q1 2024 was ¥522,905,178.52, representing a 43.0% increase from ¥365,684,199.67 in Q1 2023[17] - Total comprehensive income for the first quarter reached CNY 489,884,389.27, an increase from CNY 387,796,905.83 in the previous year[18] - Basic earnings per share increased to CNY 0.57 from CNY 0.51 year-over-year[18] - The company’s total revenue from sales of goods and services was CNY 9,922,704,952.18, compared to CNY 7,783,937,794.70 in the previous year, marking a growth of approximately 27.5%[19] Cash Flow and Liquidity - The net cash flow from operating activities improved significantly to ¥781,639,663.92, a 188.08% increase from a negative cash flow of -¥887,398,973.07 in Q1 2023[3] - The cash and cash equivalents at the end of Q1 2024 were reported at ¥7,470,499,720.99[15] - Cash inflow from operating activities totaled CNY 10,664,914,514.61, compared to CNY 8,399,245,722.82 in the same period last year, reflecting a growth of approximately 27%[19] - Cash and cash equivalents at the end of the period amounted to CNY 11,599,636,291.62, up from CNY 8,573,434,006.32 year-over-year[20] - Cash inflow from financing activities was CNY 5,227,429,346.11, compared to CNY 2,556,351,865.31 in the previous year, indicating a substantial increase[20] - The company reported a net cash outflow from investing activities of CNY -1,492,761,131.70, an improvement from CNY -2,229,869,750.08 in the previous year[20] - The company received CNY 512,649,386.29 from new investments, a significant increase from CNY 24,225,120.00 in the previous year[20] Assets and Liabilities - Total assets as of March 31, 2024, were ¥64,177,305,416.29, reflecting a 3.20% increase from ¥62,186,283,832.73 at the end of the previous year[3] - Total liabilities increased to ¥35,238,563,958.78 in Q1 2024, up from ¥34,262,590,827.28 in Q1 2023[16] - The company's equity attributable to shareholders reached ¥28,938,741,457.51, an increase from ¥27,923,693,005.45 year-over-year[16] - The long-term borrowings rose to ¥15,677,859,078.60, compared to ¥13,832,291,109.73 in the previous year[16] Shareholder Information - The total number of common shareholders at the end of the reporting period was 28,545, with the top 10 shareholders holding 51.36% of the shares[8] - Hunan Zhongwei Holdings Group Co., Ltd. holds 344,000,000 shares, representing 51.36% of the total shares[8] - The number of shares held by the top 10 unrestricted shareholders includes 344,000,000 shares held by Hunan Zhongwei Holdings Group Co., Ltd.[8] - The total amount of shares repurchased so far is 3,885,100, accounting for approximately 0.58% of the total share capital[12] Business Development - The company established a new subsidiary, C&P Advanced Material Technology Co., Ltd., to enhance its business development and market competitiveness[13] - The company has not reported any significant impact on production and operations from the establishment of the new subsidiary[13] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[17] Financial Assets and Liabilities - The company experienced a significant decrease in financial assets, with trading financial assets dropping by 50.51% to ¥60,602,715.79 due to fluctuations in hedging instruments[6] - The company's contract liabilities increased by 77.30% to ¥300,070,371.86, attributed to the growth in customer prepayments[6] - The company reported a decrease in trading financial assets from RMB 122,462,292.67 to RMB 60,602,715.79[14] - Accounts receivable increased to RMB 4,705,706,404.62 from RMB 3,752,892,890.31, indicating a growth in sales or credit terms[14] - The company reported a significant increase in accounts receivable, totaling ¥747,134,006.99, compared to the previous period[15]